BackDrugs Made In America Acquisition Units Overview

Drugs Made In America Acquisition Units Total Liabilities

Drugs Made In America Acquisition Units's total liabilities is $9.1M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$9.14M
↑ 26.87% YoYΔ $1.94M vs prior year quarter

Peer trimmed avg / median

Loading

Drugs Made In America Acquisition Units Total Liabilities History

Loading

Drugs Made In America Acquisition Units vs. peers: Total Liabilities Comparison

Loading

Drugs Made In America Acquisition Units Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Drugs Made In America Acquisition Units (DMAAU) FAQ

As of the most recent data (June 2026), DMAAU shows a total liabilities of $9.1M. That compares with $7.2M in the prior-year period — up 26.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, DMAAU's total liabilities is now $9.1M (was $7.2M) — a 26.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Drugs Made In America Acquisition Units is outperforming or lagging.

Tracking DMAAU's total liabilities over time shows whether Drugs Made In America Acquisition Units is scaling, shrinking, or reshaping that part of the business. The current reading is $9.1M That compares with $7.2M in the prior-year period — up 26.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Drugs Made In America Acquisition Units's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $9.1M) with ownership activity and broader fundamentals.